Odyssey Health (ODYY) EBIT Growth (5y) (2019 - 2026)
Odyssey Health (ODYY) EBIT Growth (5y) (2019 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 201.40 Bn | 194.75 Bn | 6.27 Bn |
| 2 | Stryker | 122.29 Bn | 119.41 Bn | 3.81 Bn |
| 3 | Medtronic | 105.01 Bn | 96.40 Bn | 6.41 Bn |
| 4 | Boston Scientific | 64.81 Bn | 63.59 Bn | 3.61 Bn |
| 5 | Edwards Lifesciences | 55.28 Bn | 51.60 Bn | 1.29 Bn |
| 6 | Dexcom | 29.06 Bn | 27.94 Bn | 750.30 Mn |
| 7 | Koninklijke Philips | 29.02 Bn | 25.93 Bn | 2.07 Bn |
| 8 | GE HealthCare Technologies | 28.27 Bn | 26.20 Bn | 1.98 Bn |
| 9 | Smith & Nephew | 25.80 Bn | 25.22 Bn | - |
| 10 | Odyssey Health | 1.08 Mn | 782,508.17 | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Apr 30, 2026 | 52.34% |
| Jan 31, 2026 | 22.09% |
| Oct 31, 2025 | 10.41% |
| Jul 31, 2025 | 33.04% |
| Apr 30, 2025 | 31.69% |
| Jan 31, 2025 | 20.71% |
| Oct 31, 2024 | 15.22% |
| Jul 31, 2024 | 14.99% |
| Apr 30, 2024 | -52.47% |
| Jan 31, 2024 | -66.76% |
| Oct 31, 2023 | -45.97% |
| Jul 31, 2023 | -51.61% |
| Apr 30, 2023 | -80.33% |
| Jan 31, 2023 | -45.02% |
| Oct 31, 2022 | -111.16% |
| Jul 31, 2022 | -102.99% |
| Apr 30, 2022 | -108.70% |
| Jan 31, 2022 | -137.72% |
| Oct 31, 2021 | -145.87% |
| Jul 31, 2021 | -142.60% |